NRNP 6541 Week 10 iHuman Assignment; Jacqueline Russell
Course : Walden
Submitted : Uploaded 2023
Contributed : Smantha
- $20.00
Additional labs or diagnostic tests:
- PHQ-9 Patient Health Questionnaire to determine the patient's level of depression
- CBC to rule out anemia and mononucleosis.
- TSH and FT4 to rule out hypothyroidism.
- HA1c and blood glucose level to rule out diabetes.
- Lipid panel to rule out hyperlipidemia.
- hCG, urine to rule out pregnancy.
- Cortisol, urine to rule out Cushing’s syndrome.
- Mononucleosis spot test to rule out mononucleosis, EBV.
- Urine drug screen to rule out drug use.
- Vanderbilt Assessment Scale to rule out ADHD.
Therapeutic/ Non-Therapeutic Modalities:
- Fluoxetine 10mg orally daily. Fluoxetine is a SSRI antidepressant that is the only approved pharmacologic treatment for major depressive disorder in children and adolescents (Reyad et al., 2021).
- Anxiety and depressive disorder are the most common mental health disorder in adolescence but only two-thirds of them seek professional help and fewer access a mental health specialist (Radez et al., 2022). It is important to emphasize and help this patient understand that it is ok for her to ask for help and speak to someone besides her parents about her current condition and stressors.
Social Determinants of Health:
- Depression symptoms and higher stress levels can explain the relationship between depression and an increase in BMI in girls and it is important to assess the environmental stressors, access to healthy foods, and having access to safe areas for physical activity (Fahrenkamp & Soto, 2018).
Health Promotion: There are several areas to address for this child and family and they include the following: ............ Continue
